These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 39201421)
1. Vitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker? López-Carrasco A; Vieco-Martí I; Granados-Aparici S; Acevedo-León D; Estañ-Capell N; Portugal R; Huerta-Aragonés J; Cañete A; Navarro S; Noguera R Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201421 [TBL] [Abstract][Full Text] [Related]
2. Vitronectin as a molecular player of the tumor microenvironment in neuroblastoma. Burgos-Panadero R; Noguera I; Cañete A; Navarro S; Noguera R BMC Cancer; 2019 May; 19(1):479. PubMed ID: 31117974 [TBL] [Abstract][Full Text] [Related]
3. Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line. López-Carrasco A; Martín-Vañó S; Burgos-Panadero R; Monferrer E; Berbegall AP; Fernández-Blanco B; Navarro S; Noguera R J Exp Clin Cancer Res; 2020 Oct; 39(1):226. PubMed ID: 33109237 [TBL] [Abstract][Full Text] [Related]
4. The topology of vitronectin: A complementary feature for neuroblastoma risk classification based on computer-aided detection. Vicente-Munuera P; Burgos-Panadero R; Noguera I; Navarro S; Noguera R; Escudero LM Int J Cancer; 2020 Jan; 146(2):553-565. PubMed ID: 31173338 [TBL] [Abstract][Full Text] [Related]
5. Both serum and tissue Galectin-1 levels are associated with adverse clinical features in neuroblastoma. Chen K; Cai Y; Zhang M; Wu Z; Wu Y Pediatr Blood Cancer; 2018 Sep; 65(9):e27229. PubMed ID: 29797641 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of serum vitronectin levels in human glioma. Chen MH; Lu C; Sun J; Chen XD; Dai JX; Cai JY; Chen XL J Neurol Sci; 2016 Dec; 371():54-59. PubMed ID: 27871448 [TBL] [Abstract][Full Text] [Related]
7. Plasma midkine level is a prognostic factor for human neuroblastoma. Ikematsu S; Nakagawara A; Nakamura Y; Ohira M; Shinjo M; Kishida S; Kadomatsu K Cancer Sci; 2008 Oct; 99(10):2070-4. PubMed ID: 19016768 [TBL] [Abstract][Full Text] [Related]
8. The ganglioside G Balis FM; Busch CM; Desai AV; Hibbitts E; Naranjo A; Bagatell R; Irwin M; Fox E Pediatr Blood Cancer; 2020 Jan; 67(1):e28031. PubMed ID: 31612589 [TBL] [Abstract][Full Text] [Related]
9. Plasma neuropeptide Y of children with neuroblastoma in relation to stage, age and prognosis, and tissue neuropeptide Y. Dötsch J; Christiansen H; Hänze J; Lampert F; Rascher W Regul Pept; 1998 Sep; 75-76():185-90. PubMed ID: 9802408 [TBL] [Abstract][Full Text] [Related]
10. Characterization of Vitronectin Effect in 3D Ewing Sarcoma Models: A Digital Microscopic Analysis of Two Cell Lines. López-Carrasco A; Parra-Haro K; Vieco-Martí I; Granados-Aparici S; Díaz-Martín J; Salguero-Aranda C; Acevedo-León D; de Álava E; Navarro S; Noguera R Cancers (Basel); 2024 Sep; 16(19):. PubMed ID: 39409975 [TBL] [Abstract][Full Text] [Related]
11. Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients. Morandi F; Corrias MV; Levreri I; Scaruffi P; Raffaghello L; Carlini B; Bocca P; Prigione I; Stigliani S; Amoroso L; Ferrone S; Pistoia V Cancer Immunol Immunother; 2011 Oct; 60(10):1485-95. PubMed ID: 21660451 [TBL] [Abstract][Full Text] [Related]
12. Plasma levels of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in patients with neuroblastoma. Granchi D; Garaventa A; Amato I; Paolucci P; Baldini N Int J Cancer; 2006 Jul; 119(1):146-51. PubMed ID: 16450378 [TBL] [Abstract][Full Text] [Related]
13. A physiologically relevant 3D collagen-based scaffold-neuroblastoma cell system exhibits chemosensitivity similar to orthotopic xenograft models. Curtin C; Nolan JC; Conlon R; Deneweth L; Gallagher C; Tan YJ; Cavanagh BL; Asraf AZ; Harvey H; Miller-Delaney S; Shohet J; Bray I; O'Brien FJ; Stallings RL; Piskareva O Acta Biomater; 2018 Apr; 70():84-97. PubMed ID: 29447961 [TBL] [Abstract][Full Text] [Related]
14. Exendin-4 induces cell adhesion and differentiation and counteracts the invasive potential of human neuroblastoma cells. Luciani P; Deledda C; Benvenuti S; Squecco R; Cellai I; Fibbi B; Marone IM; Giuliani C; Modi G; Francini F; Vannelli GB; Peri A PLoS One; 2013; 8(8):e71716. PubMed ID: 23990978 [TBL] [Abstract][Full Text] [Related]
15. Age-dependent reference intervals in children for the disialoganglioside, G Busch CM; Balis FM Clin Biochem; 2022 Mar; 101():1-4. PubMed ID: 34929151 [TBL] [Abstract][Full Text] [Related]
16. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells. Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333 [TBL] [Abstract][Full Text] [Related]
17. Shed tumor gangliosides and progression of human neuroblastoma. Valentino L; Moss T; Olson E; Wang HJ; Elashoff R; Ladisch S Blood; 1990 Apr; 75(7):1564-7. PubMed ID: 2317562 [TBL] [Abstract][Full Text] [Related]
18. Calcium phosphate scaffolds with defined interconnecting channel structure provide a mimetic 3D niche for bone marrow metastasized tumor cell growth. Aveic S; Davtalab R; Vogt M; Weber M; Buttler P; Tonini GP; Fischer H Acta Biomater; 2019 Apr; 88():527-539. PubMed ID: 30797105 [TBL] [Abstract][Full Text] [Related]
19. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children. Tonini GP; Boni L; Pession A; Rogers D; Iolascon A; Basso G; Cordero di Montezemolo L; Casale F; Pession A; Perri P; Mazzocco K; Scaruffi P; Lo Cunsolo C; Marchese N; Milanaccio C; Conte M; Bruzzi P; De Bernardi B J Clin Oncol; 1997 Jan; 15(1):85-93. PubMed ID: 8996128 [TBL] [Abstract][Full Text] [Related]
20. Vitronectin-based hydrogels recapitulate neuroblastoma growth conditions. Monferrer E; Dobre O; Trujillo S; González Oliva MA; Trubert-Paneli A; Acevedo-León D; Noguera R; Salmeron-Sanchez M Front Cell Dev Biol; 2022; 10():988699. PubMed ID: 36425532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]